Pre-order Enquiry
Download Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Summary
InMed Pharmaceuticals Inc. (InMed) is a pharmaceutical company that develops, produces and markets plant cannabinoid based pharmaceutical products to related healthcare markets. The company’s pipeline products are developed for the therapeutic areas of glaucoma, ocular allergies, arthritis, cancer and skin diseases, and others. Its proprietary Intelligent Cannabinoid Drug Design Platform (IDP) is used for identifying bioactive compounds. It develops cannabinoids receptors and products including Cannabidiol (CBD) and cannabinol (CBN). InMed’s botanical research team develops individual strains and clones. The company also partners with University of British Columbia and University of Debrecen. InMed is headquartered in Vancouver, British Columbia, Canada.
InMed Pharmaceuticals Inc. Key Recent Developments
Jun 16, 2016: InMed Announces Appointment of Eric A. Adams as CEO, President and Director
Feb 16, 2016: InMed Announces Update on Biosynthesis Project
Nov 23, 2015: InMed Strengthens Board With Appointment of Experienced Biotech Executive Adam Cutler
Sep 03, 2015: InMed Appoints Paul Brennan as President & Chief Executive Officer
Aug 25, 2015: InMed Appoints Paul Brennan to the Board of Directors
This comprehensive SWOT profile of InMed Pharmaceuticals Inc. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the 'Profile on Demand' Service, covering over 50,000 of the world's leading companies. Once purchased, We will comprehensively research and author a full strategic analysis of InMed Pharmaceuticals Inc. and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company's operations and business divisions.
- Corporate strategy – Analyst's summarization of the company's business strategy.
- SWOT Analysis – A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives' employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
InMed Pharmaceuticals Inc. (InMed) is a pharmaceutical company that develops, produces and markets plant cannabinoid based pharmaceutical products to related healthcare markets. The company’s pipeline products are developed for the therapeutic areas of glaucoma, ocular allergies, arthritis, cancer and skin diseases, and others. Its proprietary Intelligent Cannabinoid Drug Design Platform (IDP) is used for identifying bioactive compounds. It develops cannabinoids receptors and products including Cannabidiol (CBD) and cannabinol (CBN). InMed’s botanical research team develops individual strains and clones. The company also partners with University of British Columbia and University of Debrecen. InMed is headquartered in Vancouver, British Columbia, Canada.
InMed Pharmaceuticals Inc. Key Recent Developments
Jun 16, 2016: InMed Announces Appointment of Eric A. Adams as CEO, President and Director
Feb 16, 2016: InMed Announces Update on Biosynthesis Project
Nov 23, 2015: InMed Strengthens Board With Appointment of Experienced Biotech Executive Adam Cutler
Sep 03, 2015: InMed Appoints Paul Brennan as President & Chief Executive Officer
Aug 25, 2015: InMed Appoints Paul Brennan to the Board of Directors
This comprehensive SWOT profile of InMed Pharmaceuticals Inc. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the 'Profile on Demand' Service, covering over 50,000 of the world's leading companies. Once purchased, We will comprehensively research and author a full strategic analysis of InMed Pharmaceuticals Inc. and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company's operations and business divisions.
- Corporate strategy – Analyst's summarization of the company's business strategy.
- SWOT Analysis – A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives' employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
Frequently Asked Questions
This market study covers the global and regional market with an
in-depth analysis of the
overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by
highlighting information on
different aspects including drivers, restraints...
